Gambaran Umum
Sinopharm Group Company Limited, based in China, is a healthcare company specializing in the distribution of pharmaceuticals and medical devices.. It operates through three segments: pharmaceutical distribution to hospitals, retailers, and clinics; pharmaceutical retailing through chain stores; and other operations including lab supply distribution, chemical reagent manufacturing and sales, and property leasing. The company also provides pharmaceutical logistics services in China through its subsidiaries.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah 575,824.12 MM.
- Nilai operating income untuk Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah 17,265.35 MM.
- Nilai net income untuk Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah 6,810.75 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 575,824.12 | 17,265.35 | 6,810.75 |
2025-03-31 | 578,903.72 | 17,599.67 | 7,086.51 |
2024-12-31 | 584,507.93 | 17,819.06 | 7,049.68 |
2024-09-30 | 590,267.17 | 20,740.02 | 8,327.02 |
2024-06-30 | 590,346.10 | 20,739.81 | 8,645.97 |
2024-03-31 | 598,317.59 | 21,690.20 | 8,883.56 |
2023-12-31 | 596,569.56 | 22,318.49 | 9,053.76 |
2023-09-30 | 591,685.68 | 22,501.78 | 8,765.04 |
2023-06-30 | 591,626.11 | 23,084.51 | 8,936.35 |
2023-03-31 | 570,067.28 | 23,018.71 | 8,688.12 |
2022-12-31 | 552,147.55 | 22,764.17 | 8,525.66 |
2022-09-30 | 546,147.06 | 21,488.53 | 7,914.33 |
2022-06-30 | 533,402.73 | 21,424.17 | 7,869.55 |
2022-03-31 | 528,383.05 | 21,529.84 | 7,970.37 |
2021-12-31 | 521,051.23 | 20,983.76 | 7,758.65 |
2021-09-30 | 510,090.53 | 20,422.96 | 7,930.02 |
2021-06-30 | 501,770.13 | 20,593.90 | 7,874.44 |
2021-03-31 | 474,798.48 | 18,525.45 | 6,955.59 |
2020-12-31 | 456,414.61 | 19,102.09 | 7,187.28 |
2020-09-30 | 440,194.47 | 18,473.78 | 6,615.77 |
2020-06-30 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | 2.26 | |
2024-09-30 | 2.67 | 2.67 |
2024-06-30 | 2.78 | 2.78 |
2024-03-31 | 2.99 | 2.99 |
2023-12-31 | 2.90 | |
2023-09-30 | 2.81 | 2.81 |
2023-06-30 | 2.87 | 2.87 |
2023-03-31 | 2.78 | 2.78 |
2022-12-31 | 2.74 | |
2022-09-30 | 2.54 | 2.54 |
2022-06-30 | 2.52 | 2.52 |
2022-03-31 | 2.56 | 2.56 |
2021-12-31 | 2.49 | |
2021-09-30 | 2.47 | 2.47 |
2021-06-30 | 2.52 | 2.53 |
2021-03-31 | 2.23 | 2.23 |
2020-12-31 | 2.31 | 2.31 |
2020-09-30 | 2.21 | 2.21 |
2020-06-30 | 2.03 | 2.03 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah 18,428.59 MM.
- Nilai cash from investing activities untuk Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah -3,243.66 MM.
- Nilai kas dari aktivitas pendanaan untuk Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah -23,257.79 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 18,428.59 | -3,243.66 | -23,257.79 |
2025-03-31 | 24,751.68 | -3,389.55 | -26,563.07 |
2024-12-31 | 11,546.01 | -3,750.93 | -17,285.03 |
2024-09-30 | 3,573.97 | -6,836.24 | 13,815.23 |
2024-06-30 | 19,505.79 | -3,163.53 | -7,388.20 |
2024-03-31 | 10,385.32 | -1,104.43 | -6,600.15 |
2023-12-31 | 17,173.03 | -944.53 | -7,643.97 |
2023-09-30 | 21,349.36 | 2,859.21 | -18,087.44 |
2023-06-30 | 11,930.75 | -2,800.17 | -6,911.05 |
2023-03-31 | 16,763.45 | -3,256.47 | -4,307.59 |
2022-12-31 | 20,963.79 | -3,589.62 | -5,693.48 |
2022-09-30 | 38,424.87 | -4,354.21 | -26,767.44 |
2022-06-30 | 2,783.06 | -964.24 | -4,039.89 |
2022-03-31 | 7,658.25 | -1,566.25 | -8,309.30 |
2021-12-31 | 9,308.08 | -1,266.96 | -14,693.01 |
2021-09-30 | 6,794.81 | -1,460.43 | -12,270.41 |
2021-06-30 | 10,982.86 | -4,105.08 | -11,854.36 |
2021-03-31 | -9,890.37 | -2,815.92 | 2,496.56 |
2020-12-31 | 11,154.61 | -2,202.76 | 2,025.85 |
2020-09-30 | 8,074.68 | -4,677.05 | 1,345.83 |
2020-06-30 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 |
Efektivitas Manajemen
- roa untuk Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.02.
- roe untuk Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.06.
- roic untuk Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.03.
- croic untuk Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.02.
- ocroic untuk Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.09.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | 0.02 | 0.06 | 0.03 | -0.02 | 0.09 |
2025-03-31 | 0.02 | 0.06 | 0.03 | -0.05 | 0.06 |
2024-12-31 | 0.02 | 0.06 | 0.04 | 0.04 | 0.09 |
2024-09-30 | 0.02 | 0.07 | 0.03 | 0.03 | 0.07 |
2024-06-30 | 0.02 | 0.08 | 0.03 | 0.01 | 0.04 |
2024-03-31 | 0.02 | 0.08 | 0.03 | 0.03 | 0.07 |
2023-12-31 | 0.02 | 0.08 | 0.03 | 0.02 | 0.08 |
2023-09-30 | 0.02 | 0.09 | 0.03 | 0.01 | 0.05 |
2023-06-30 | 0.02 | 0.09 | 0.03 | 0.01 | 0.05 |
2023-03-31 | 0.02 | 0.08 | 0.04 | 0.04 | 0.07 |
2022-12-31 | 0.02 | 0.08 | 0.03 | 0.02 | 0.03 |
2022-09-30 | 0.02 | 0.08 | 0.03 | 0.02 | 0.03 |
2022-06-30 | 0.02 | 0.08 | 0.03 | -0.01 | 0.01 |
2022-03-31 | 0.03 | 0.09 | 0.04 | -0.01 | 0.04 |
2021-12-31 | 0.02 | 0.09 | 0.03 | -0.03 | 0.04 |
2021-09-30 | 0.02 | 0.09 | 0.03 | -0.03 | 0.03 |
2021-06-30 | 0.03 | 0.10 | 0.04 | -0.03 | 0.06 |
2021-03-31 | 0.03 | 0.09 | 0.04 | -0.04 | 0.04 |
2020-12-31 | 0.03 | 0.09 | 0.03 | 0.05 | 0.05 |
2020-09-30 | 0.02 | 0.09 | 0.03 | 0.02 | 0.03 |
2020-06-30 | 0.02 | 0.09 | 0.03 | 0.03 | 0.02 |
Gross Margins
- marjin kotor untuk Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.08.
- marjin bersih untuk Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.01.
- marjin operasi untuk Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.03.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.08 | 0.01 | 0.03 |
2025-03-31 | 0.08 | 0.01 | 0.03 |
2024-12-31 | 0.08 | 0.01 | 0.04 |
2024-09-30 | 0.08 | 0.01 | 0.04 |
2024-06-30 | 0.08 | 0.01 | 0.04 |
2024-03-31 | 0.08 | 0.02 | 0.04 |
2023-12-31 | 0.08 | 0.01 | 0.04 |
2023-09-30 | 0.08 | 0.02 | 0.04 |
2023-06-30 | 0.08 | 0.02 | 0.04 |
2023-03-31 | 0.09 | 0.02 | 0.04 |
2022-12-31 | 0.08 | 0.01 | 0.04 |
2022-09-30 | 0.08 | 0.01 | 0.04 |
2022-06-30 | 0.08 | 0.01 | 0.04 |
2022-03-31 | 0.08 | 0.02 | 0.04 |
2021-12-31 | 0.08 | 0.01 | 0.04 |
2021-09-30 | 0.09 | 0.02 | 0.04 |
2021-06-30 | 0.09 | 0.02 | 0.04 |
2021-03-31 | 0.09 | 0.02 | 0.04 |
2020-12-31 | 0.09 | 0.02 | 0.04 |
2020-09-30 | 0.09 | 0.02 | 0.04 |
2020-06-30 | 0.09 | 0.01 | 0.04 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |
Grupong Pang-industriya
SIC 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries |